Trademark: 85728986
Word
ICLUSIG PONATINIB
Status Date
Monday, November 10, 2014
Filing Date
Friday, September 14, 2012
Published for Opposition
Tuesday, February 12, 2013
Abandoned Date
Monday, November 10, 2014
5 Pharmaceutical preparations for use in oncology containing ponatinib
Color is not claimed as a feature of the mark.
"PONATINIB"
The mark consists of the word "iclusig" in lower case letters, underlined up to the letter "g", with the word "ponatinib" in lower case letters below it. The first "i" in 'iclusig' has a dot over it that is partially encircled.
Nov 10, 2014
Abandonment Notice Mailed - No Use Statement Filed
Nov 10, 2014
Abandonment - No Use Statement Filed
Apr 4, 2014
Notice Of Approval Of Extension Request E-Mailed
Apr 2, 2014
Extension 2 Granted
Apr 2, 2014
Extension 2 Filed
Apr 2, 2014
Teas Extension Received
Oct 10, 2013
Notice Of Approval Of Extension Request E-Mailed
Oct 8, 2013
Extension 1 Granted
Oct 8, 2013
Extension 1 Filed
Oct 8, 2013
Teas Extension Received
Apr 9, 2013
Noa E-Mailed - Sou Required From Applicant
Feb 12, 2013
Official Gazette Publication Confirmation E-Mailed
Feb 12, 2013
Published For Opposition
Jan 23, 2013
Notification Of Notice Of Publication E-Mailed
Jan 9, 2013
Law Office Publication Review Completed
Jan 9, 2013
Assigned To Lie
Dec 18, 2012
Approved For Pub - Principal Register
Dec 18, 2012
Examiner's Amendment Entered
Dec 18, 2012
Notification Of Examiners Amendment E-Mailed
Dec 18, 2012
Examiners Amendment E-Mailed
Dec 18, 2012
Examiners Amendment -Written
Nov 21, 2012
Previous Allowance Count Withdrawn
Nov 11, 2012
Withdrawn From Pub - Og Review Query
Oct 24, 2012
Approved For Pub - Principal Register
Oct 22, 2012
Assigned To Examiner
Sep 20, 2012
Notice Of Design Search Code Mailed
Sep 19, 2012
New Application Office Supplied Data Entered In Tram
Sep 18, 2012
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
